Haro Hartounian, the senior vice president and general manager for Biopharma at NJII, discussed at ISCT 2020 how the division’s cell and gene therapy development and manufacturing center, BioCentriq, is advancing therapies and building the workforce of the future. Watch it now!
This presentation was conducted as part of the ISCT 2020 Paris Virtual Meeting http://www.isct2020.com/. To learn more about our Biopharma Division, please visit www.njii.com/biopharma. To learn more about BioCentriq, visit www.biocentriq.com.
ISCT Paris 2020 Virtual
May 28, 2020
May 29, 2020
SCT is a global society of clinicians, regulators, technologists, and industry partners with a shared vision to translate cellular therapy into safe and effective therapies to improve patients' lives. ISCT Members gain access to an influential global community of peers, experts, and organizations invested in cell therapy. ISCT offers a unique collaboration between academia, regulatory bodies, and industry partners in cell therapy translation This is their annual event.